Lund University Researcher Releases New Data on Osteosarcomas (Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma)

MLA

“Lund University Researcher Releases New Data on Osteosarcomas (Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma).” Obesity, Fitness & Wellness Week, Sept. 2024, p. 643. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.807727992&authtype=sso&custid=ns315887.

APA

Lund University Researcher Releases New Data on Osteosarcomas (Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma). (2024, September 14). Obesity, Fitness & Wellness Week, 643.

Chicago

Obesity, Fitness & Wellness Week. 2024. “Lund University Researcher Releases New Data on Osteosarcomas (Surgery Combined with Local Implantation of Doxorubicin-Functionalized Hydroxyapatite Halts Tumor Growth and Prevents Bone Destruction in an Aggressive Osteosarcoma),” September 14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.807727992&authtype=sso&custid=ns315887.